About
NeoMedLight is a medical device company focused on innovative phototherapy solutions using proprietary technology that emits light through woven optic fibers. Founded as a spin-off from Brochier Technologies, the company develops advanced medical devices primarily for phototherapy applications. Their flagship product, Bilicocoon, is designed for treating neonatal jaundice and is available in 30 countries. Another key product is CareMin650™, a CE-marked device launched in March 2020, which utilizes red LED photobiomodulation to prevent and treat complications from cancer treatments, such as mucositis and dermatitis. CareMin650™ features specialized treatment pads, including Oral Pads for oral mucositis and a Derma Pad for radiation dermatitis. Headquartered in Villeurbanne, Auvergne, France, NeoMedLight combines expertise in medical devices and technical weaving. The company aims to enhance patient comfort and treatment efficacy through its patented fiber-optic technology, targeting hospitals and healthcare providers to improve patient outcomes in neonatal and oncology care.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2014
-
Total Funding $3246584
Location
90 Rue Frederic Fays, Villeurbanne, Auvergne-Rhone-Alpes, France, 69100